Nippon Shokubai and Arkema: a strategic partnership to mass-produce LiFSI electrolytic salt for a European battery chain

OSAKA, Japan, May 31, 2022–Nippon Shokubai and Arkema are partnering to publish feasibility studies and create a joint venture for the structure of a commercial plant for the production of ultrapure electrolytic salt LiFSI (Lithium bis(fluorosulfonyl)imide), a key component of battery cells for mobility.

Nippon Shokubai and Arkema: a strategic partnership to mass-produce LiFSI electrolytic salt for a European battery chain Read More »

Can the generation diversify clinical trials?

As the shift to working from home has proliferated by the pandemic, work has become decentralized, and many businesses have been able to be productive with a home-based workforce. Teams and Zoom have become the backbone of communication and companies have adopted new work tactics. The same principles are increasingly being implemented in clinical trials to improve diversity, mitigate bias, and strengthen inclusion in clinical trials.

Can the generation diversify clinical trials? Read More »

A network of distributed sensors can reveal physical processes that contribute to the formation of sea ice

Despite its sub-zero temperatures, the Arctic is warming twice as fast as the rest of the planet. As Arctic sea ice melts, you have fewer shiny surfaces to reflect sunlight back into space. When fractures open in the ice sheet, the water below is exposed. Dark, ice-free water absorbs the sun

A network of distributed sensors can reveal physical processes that contribute to the formation of sea ice Read More »